LMNX Share Price

Open 18.93 Change Price %
High 19.04 1 Day -0.11 -0.58
Low 18.71 1 Week 0.58 3.18
Close 18.83 1 Month 0.69 3.80
Volume 169833 1 Year -1.27 -6.32
52 Week High 23.75
52 Week Low 17.64
LMNX Important Levels
Resistance 2 19.14
Resistance 1 19.01
Pivot 18.86
Support 1 18.65
Support 2 18.52
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
INTC 36.15 -3.42%
INTC 36.15 -3.42%
INTC 36.15 -3.42%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
SPIR 0.02 100.00%
LOCM 0.09 50.00%
MYRX 0.08 33.33%
STRT 32.15 30.16%
WRES 0.09 28.57%
TBBK 6.45 27.47%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
EHTH 14.18 20.78%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LLEN 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
ROSE 10.35 -48.20%
ROSE 10.35 -48.20%
DVOX 0.05 -44.44%
More..

Luminex Corporation (NASDAQ: LMNX)

LMNX Technical Analysis 2.5
As on 28th Apr 2017 LMNX Share Price closed @ 18.83 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 20.34 & Strong Buy for SHORT-TERM with Stoploss of 18.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
LMNX Target for April
1st Target up-side 19.09
2nd Target up-side 19.59
3rd Target up-side 20.1
1st Target down-side 17.65
2nd Target down-side 17.15
3rd Target down-side 16.64
LMNX Other Details
Segment EQ
Market Capital 700786944.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.luminexcorp.com
LMNX Address
LMNX
12212 Technology Boulevard
Austin, TX 78727
United States
Phone: 512-219-8020
Fax: 512-219-5195
LMNX Latest News
Interactive Technical Analysis Chart Luminex Corporation ( LMNX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Luminex Corporation
LMNX Business Profile
Luminex Corporation (Luminex)develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The Company�s Multi-Analyte Profiling (xMAP) technology, an open architecture, multiplexing technology, allows simultaneous analysis of up to 500 bioassays from a small sample volume, a single drop of fluid, by reading biological tests on the surface of microscopic polystyrene beads called microspheres. xMAP technology combines this miniaturized liquid array bioassay capability with small lasers, digital signal processors and software. Its xMAP technology is being used within various segments of the life sciences industry, which includes the fields of drug discovery and development, and for clinical diagnostics, genetic analysis, bio-defense, food safety and biomedical research. On June 27, 2011, the Company completed its acquisition of 100% interest of EraGen Biosciences, Inc.